Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics

Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics

Abstract Background Esophageal squamous cell carcinoma (ESCC), the most common type of esophageal cancer, characterized by low five-year survival rate, and concurrent chemoradiotherapy (CCRT) has been proposed to treat ESCC, while potential biomarkers for prognostic monitoring after optimized CCRT r...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Yang, Yunyun Zhu, Yijian Zhou, Jiaying Zhang, Yuxuan Wei, Yongpan Liu, Bo Zhang, Jialing Xie, Xiaolu An, Xianhua Qi, Yuting Yue, Lijia Zhang, Xiajun Zhang, Zhichao Fu, Kuancan Liu
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cancer
Subjects:
Esophageal squamous cell carcinoma
Metabolomics
CCRT
Prognosis
Biomarkers
Online Access:https://doi.org/10.1186/s12885-025-13866-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13866-x

Similar Items